Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
Biol Blood Marrow Transplant
; 26(7): e147-e160, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-116923
ABSTRACT
The full impact of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on the field of hematopoietic cell transplantation (HCT) is unknown. This perspective paper reviews the following current COVID-19 epidemiology, diagnosis, and potential therapies; care considerations unique to HCT recipients; and the concept of a learning network to assimilate emerging guidelines and best practices and to optimize patient outcomes through facilitating shared learning and experience across transplantation centers.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Bone Marrow Transplantation
/
Coronavirus Infections
/
Hematopoietic Stem Cell Transplantation
/
Pandemics
/
Betacoronavirus
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Biol Blood Marrow Transplant
Journal subject:
Hematology
/
Transplantation
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS